Education
About Us
Working with TipRanks
Follow Us
Panacos Pharmaceuticals Inc (PANC)
OTHER OTC:PANC
PANC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.05 - $0.05
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$54.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)8.82M
Price to Earnings (P/E)―
Beta-3.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,640,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
PANC FAQ
What was Panacos Pharmaceuticals Inc’s price range in the past 12 months?
Panacos Pharmaceuticals Inc lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
What is Panacos Pharmaceuticals Inc’s market cap?
Panacos Pharmaceuticals Inc’s market cap is $54.00.
When is Panacos Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Panacos Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Panacos Pharmaceuticals Inc overvalued?
According to Wall Street analysts Panacos Pharmaceuticals Inc’s price is currently Overvalued.
Does Panacos Pharmaceuticals Inc pay dividends?
Panacos Pharmaceuticals Inc does not currently pay dividends.
What is Panacos Pharmaceuticals Inc’s EPS estimate?
Panacos Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacos Pharmaceuticals Inc have?
Panacos Pharmaceuticals Inc has 53,640,000 shares outstanding.
What happened to Panacos Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Panacos Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in PANC
---
Company Description
Panacos Pharmaceuticals Inc
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
---
Technical Analysis
Biodexa Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Ocean Biomedical
―
Onconetix
―
---